Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NIMA Partners is a private healthtech and consumer diagnostics company focused on helping people with celiac disease and gluten-related disorders assess food safety in real time. The company commercializes the NIMA Gluten Sensor, a handheld portable testing device that uses single-use capsules containing proprietary antibody-based chemistry to detect gluten in food samples. NIMA also supports its product ecosystem with a mobile application and related consumer services for gluten-free living. While it is not a therapeutic biotech developer, it operates in healthcare-adjacent diagnostics and food safety with a commercial-stage product aimed at improving daily disease management and quality of life.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NIMA Partners.